1. Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy
- Author
-
Julian Frederic Hotz, Moritz Staudacher, Katharina Schefberger, Kathrin Spettel, Katharina Schmid, Richard Kriz, Lisa Schneider, Jürgen Benjamin Hagemann, Norbert Cyran, Katy Schmidt, Peter Starzengruber, Felix Lötsch, Amelie Leutzendorff, Simon Daller, Michael Ramharter, Heinz Burgmann, and Heimo Lagler
- Subjects
MRSA ,Dalbavancin ,Whole genome sequencing ,Antimicrobial resistance ,Linezolid ,Daptomycin ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. Methods This study investigated 55 MRSA bloodstream isolates (02/2015–02/2021) from the University Hospital of the Medical University of Vienna, Austria. The MICs of dalbavancin, linezolid, and daptomycin were assessed. Two isolates (16–33 and 19–362) resistant to dalbavancin were analyzed via whole-genome sequencing, with morphology evaluated using transmission electron microscopy (TEM). Results S.aureus BSI strain 19–362 had two novel missense mutations (p.I515M and p.A606D) in the pbp2 gene. Isolate 16–33 had a 534 bp deletion in the DHH domain of GdpP and a SNV in pbp2 (p.G146R). Both strains had mutations in the rpoB gene, but at different positions. TEM revealed significantly thicker cell walls in 16–33 (p
- Published
- 2024
- Full Text
- View/download PDF